Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Ophthalmology

Biology & Diagnosis: How CMV Retinitis is Identified

At a Glance

CMV retinitis is usually found during a dilated eye exam, when a retina specialist looks for its characteristic white-and-red retinal lesions. A negative blood test cannot rule it out because infection may be limited to the eye; OCT, photos, or eye-fluid PCR can help when findings are uncertain.

Diagnosing Cytomegalovirus (CMV) retinitis is a bit like detective work. Because the virus often hides in the body without causing symptoms, doctors must rely on specific visual patterns and specialized tests to find it before it causes permanent damage [1][2].

The Biology of Reactivation

CMV is a “latent” virus, meaning it can stay dormant in your body for years without you knowing it [3]. It resides in specific immune cells such as myeloid progenitors (bone marrow cells) and monocytes (a type of white blood cell) [3][4]. Under normal conditions, your immune system keeps the virus “asleep.”

When your immune system becomes severely weakened—such as when a CD4 count drops below 50 in HIV or during intense suppression after a transplant—this control is lost [5][6]. The virus then “reactivates,” begins to multiply, and can travel through the bloodstream to the eye [7]. Once in the eye, it infects multiple cell types, including the retinal pigment epithelium (the support layer of the retina) and the blood vessels, leading to vascular injury and the death of retinal tissue, known as necrosis [8][9].

What the Specialist Sees

The most common way CMV retinitis is diagnosed is through a dilated fundus exam, where a retina specialist uses special lenses to look at the back of your eye [1]. They are looking for several classic “signatures”:

  • The “Pizza-Pie” Appearance: This is a classic medical term for a retina that shows a mix of white, cloudy areas (the dead retinal tissue) and bright red spots (hemorrhages or bleeding) [2][10]. It is sometimes also called the “cheese and ketchup” appearance [2].
  • Granular Borders: The edge of the infection often looks “grainy” or like fine white sand, which shows where the virus is actively moving into healthy tissue [1][11].
  • Wedge-Shaped Lesions: The infection often follows the path of blood vessels, creating a triangle or wedge shape on the retina [1].

Differentiating CMV from Other Infections

Not every retinal infection is CMV. Specialists must distinguish it from other conditions that can look similar but require different treatments:

  • Acute Retinal Necrosis (ARN) or PORN (Progressive Outer Retinal Necrosis): Usually caused by the herpes simplex virus (HSV) or the shingles virus (VZV) [12]. These tend to move much faster than CMV [12][13][14].
  • Other Mimics: Fungal infections, toxoplasmosis, and syphilis can also cause severe inflammation and require different directed testing.
  • Endophthalmitis: A general term for severe inflammation or infection inside the eye, often following surgery [15]. The presence of unexplained endophthalmitis-like inflammation in an immunocompromised patient should raise suspicion for viral causes [15][16].

Why Blood Tests Aren’t Enough

A common misconception is that a “negative” blood test for CMV means your eyes are safe. This is not true.

  • Compartmentalization: The eye is a “protected” space. The virus can be active and destructive in the eye even if it is not detectable in your blood [17][18]. In one study context, only about 14% of patients with active CMV retinitis had the virus show up in their blood tests [17].
  • Intraocular PCR: If the diagnosis is unclear or atypical, your doctor may perform a procedure to take a tiny sample of fluid from the front (aqueous humor) or back (vitreous humor) of your eye [19][20]. This fluid is then tested using PCR (Polymerase Chain Reaction) to look for CMV DNA [19]. This test supports the diagnosis but carries procedural risks and is generally reserved for uncertain cases; a negative PCR does not completely rule out disease after treatment [17]. Classic lesions are often diagnosed clinically without this test.

Imaging Tools

To confirm the diagnosis and track your progress, your doctor may use:

  • Optical Coherence Tomography (OCT): A non-invasive “ultrasound with light” that takes high-resolution cross-section pictures of your retina to see the extent of tissue damage [21][22].
  • Fundus Photography: High-quality color photos (including “ultra-widefield” views) that allow the doctor to map the infection and see if it is growing or shrinking over time [10][23].

Common questions in this guide

What does the “pizza-pie” appearance mean in CMV retinitis?
It describes a mix of cloudy white patches and bright red areas of bleeding on the retina. This pattern is a classic clue for CMV retinitis, but the eye specialist considers the full exam and may order additional tests.
Can a negative blood test rule out CMV retinitis?
No. CMV can be active in the eye without being detectable in the bloodstream, so a negative blood result does not prove the retina is unaffected. A dilated eye exam, and sometimes testing of eye fluid, may still be needed.
How is CMV retinitis usually diagnosed?
A retina specialist usually makes the diagnosis during a dilated examination of the back of the eye, looking for characteristic areas of retinal damage, bleeding, and active borders. OCT scans and fundus photographs can show the extent of injury and help track changes over time.
When is an eye-fluid PCR test used for CMV retinitis?
If the retinal appearance is unusual or the diagnosis is uncertain, a clinician may collect a small sample of fluid from the front or back of the eye and test it for CMV DNA. Because sampling has procedural risks, it is generally not needed when the exam is classic, and a negative result after treatment does not completely exclude disease.
How do doctors distinguish CMV retinitis from HSV or VZV retinal infections?
They compare the speed of progression and the pattern of retinal damage, because HSV- and VZV-related necrotizing infections can move faster than CMV. The clinician may also use targeted tests and consider other causes such as fungal infection, toxoplasmosis, or syphilis.
What does my immune status have to do with CMV retinitis?
CMV can stay dormant for years while a healthy immune system keeps it controlled. Severe immune suppression, such as a CD4 count below 50 in HIV or strong anti-rejection treatment after transplant, can allow the virus to reactivate and reach the retina.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific patterns did you see on my retina, and did they have the 'pizza-pie' appearance typical of CMV?
  2. 2.Since my blood CMV test was negative, why are you still concerned about my eyes, and would an aqueous fluid PCR provide more certainty?
  3. 3.How do you know this is CMV and not another virus like the one that causes shingles (VZV) or cold sores (HSV)?
  4. 4.Is the infection located in my 'peripheral' retina or near my 'macula,' and how does that change the urgency of my treatment?
  5. 5.Do my imaging tests (OCT or fundus photos) show any signs of 'retinal necrosis' or 'vasculitis' that I should be aware of?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Classification Criteria for Cytomegalovirus Retinitis.

    American journal of ophthalmology 2021; (228()):245-254 doi:10.1016/j.ajo.2021.03.051.

    PMID: 33845015
  2. 2

    Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment.

    Zhang J, Kamoi K, Zong Y, et al.

    Viruses 2024; (16(9)) doi:10.3390/v16091427.

    PMID: 39339903
  3. 3

    Sleepless latency of human cytomegalovirus.

    Poole E, Sinclair J

    Medical microbiology and immunology 2015; (204(3)):421-9 doi:10.1007/s00430-015-0401-6.

    PMID: 25772624
  4. 4

    Control of Cytokines in Latent Cytomegalovirus Infection.

    Chinta P, Garcia EC, Tajuddin KH, et al.

    Pathogens (Basel, Switzerland) 2020; (9(10)) doi:10.3390/pathogens9100858.

    PMID: 33096622
  5. 5

    Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare.

    Leenasirimakul P, Liu Y, Jirawison C, et al.

    The British journal of ophthalmology 2016; (100(8)):1017-21 doi:10.1136/bjophthalmol-2016-308556.

    PMID: 27297217
  6. 6

    The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

    Ciáurriz M, Zabalza A, Beloki L, et al.

    Cellular and molecular life sciences : CMLS 2015; (72(21)):4049-62 doi:10.1007/s00018-015-1986-z.

    PMID: 26174234
  7. 7

    Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation.

    Jackson SE, Chen KC, Groves IJ, et al.

    Frontiers in immunology 2021; (12()):657945 doi:10.3389/fimmu.2021.657945.

    PMID: 33912186
  8. 8

    Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.

    Tabata T, Petitt M, Fang-Hoover J, et al.

    The American journal of pathology 2016; (186(11)):2970-2986 doi:10.1016/j.ajpath.2016.07.016.

    PMID: 27638253
  9. 9

    Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection.

    McCord JL, Han JYS, Staudt RE, et al.

    Science advances 2024; (10(47)):eadn6379 doi:10.1126/sciadv.adn6379.

    PMID: 39565860
  10. 10

    Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis: Multimodal Imaging in Uveitis (MUV) Task Force - Report 15.

    Leal I, Agarwal A, Berkenstock M, et al.

    Ophthalmology. Retina 2026; doi:10.1016/j.oret.2026.05.004.

    PMID: 42119730
  11. 11

    CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION.

    Fan J, Gong D, Truong C, et al.

    Retinal cases & brief reports 2022; (16(2)):199-203 doi:10.1097/ICB.0000000000000928.

    PMID: 31568220
  12. 12

    First-line management of necrotizing herpetic retinitis by prioritizing the investigation of immune status and prognostic factors for poor visual outcomes.

    Loubsens E, Adam R, Debard A, et al.

    International ophthalmology 2023; (43(7)):2545-2556 doi:10.1007/s10792-023-02656-8.

    PMID: 36920634
  13. 13

    Herpesvirus Retinitis by Immune Status: Clinical Phenotypes and Predictors of Retinal Detachment and Severe Visual Impairment.

    Zou Y, Yang M, Zhang J, et al.

    Ophthalmology. Retina 2026; doi:10.1016/j.oret.2026.06.002.

    PMID: 42252088
  14. 14

    Comparison of Clinical Characteristics Among Herpetic Retinitis: Acute Retinal Necrosis and Cytomegalovirus Retinitis.

    Hirai H, Kuraoka D, Ueda T, Kase S

    Ocular immunology and inflammation 2025; (33(8)):1679-1687 doi:10.1080/09273948.2025.2522955.

    PMID: 40556108
  15. 15

    Cytomegalovirus Retinitis with Hypopyon Similar to Bacterial Endophthalmitis in a Patient with non-Hodgkin's Lymphoma.

    Seki K, Harimoto K, Takeuchi M

    Ocular immunology and inflammation 2022; (30(7-8)):2017-2018 doi:10.1080/09273948.2021.1944647.

    PMID: 34213982
  16. 16

    Infectious uveitis in immunodeficient HIV-negative patients: A retrospective study.

    Svozilkova P, Rihova E, Brichova M, et al.

    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2020; (164(4)):410-416 doi:10.5507/bp.2019.036.

    PMID: 31435074
  17. 17

    Polymerase chain reaction analysis of aqueous humor specimens in the diagnosis of cytomegalovirus retinitis in AIDS patients.

    Mao F, Sun H, Li D, et al.

    European journal of ophthalmology 2020; (30(4)):738-742 doi:10.1177/1120672119841777.

    PMID: 30968705
  18. 18

    Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma.

    Kikuchi T, Watanabe M, Tsukada N, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2025; (27(4)):e70040 doi:10.1111/tid.70040.

    PMID: 40257295
  19. 19

    [Relationship between opacity of cytomegalovirus retinitis lesion borders and aqueous viral load among patients after allogeneic hematopoietic stem cell transplantation].

    Lu Y, Hong J, Li HP, et al.

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2022; (58(12)):1033-1038 doi:10.3760/cma.j.cn112142-20220218-00062.

    PMID: 36480884
  20. 20

    Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma.

    Tasiopoulou A, Urzua CA, Lightman S

    Eye (London, England) 2023; (37(9)):1895-1903 doi:10.1038/s41433-022-02267-0.

    PMID: 36192634
  21. 21

    OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study.

    Invernizzi A, Agarwal A, Ravera V, et al.

    Retina (Philadelphia, Pa.) 2018; (38(1)):108-117 doi:10.1097/IAE.0000000000001503.

    PMID: 28145973
  22. 22

    SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULA-INVOLVING CYTOMEGALOVIRUS RETINITIS.

    Gupta MP, Patel S, Orlin A, et al.

    Retina (Philadelphia, Pa.) 2018; (38(5)):1000-1010 doi:10.1097/IAE.0000000000001644.

    PMID: 28376042
  23. 23

    Ultra-Widefield Fundus Autofluorescence in Cytomegalovirus Retinitis.

    Tadepalli S, Bajgai P, Dogra M, et al.

    Ocular immunology and inflammation 2020; (28(3)):446-452 doi:10.1080/09273948.2019.1595671.

    PMID: 31136217

This page is for informational purposes only and does not constitute medical advice. An eye specialist should interpret your exam, imaging, and test results and guide care for your specific situation.

Get notified when new evidence is published on Cytomegalovirus retinitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.